HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

U 0126 (UO 126)

inhibits both ERK and mitogen-activated protein kinase kinase (MAPKK); structure in first source
Also Known As:
UO 126; 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene; U-0126; U0126; U0126 cpd; U126 cpd; UO-126; UO126
Networked: 513 relevant articles (20 outcomes, 31 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Armstead, William M: 11 articles (07/2012 - 01/2003)
2. Edvinsson, Lars: 8 articles (03/2015 - 04/2007)
3. Fong, Yi-Chin: 5 articles (01/2012 - 02/2009)
4. Tang, Chih-Hsin: 5 articles (01/2012 - 02/2009)
5. Cao, Jun-Li: 5 articles (02/2007 - 04/2005)
6. Zeng, Yin-Ming: 5 articles (07/2006 - 04/2005)
7. Huang, Chih-Yang: 4 articles (04/2015 - 09/2010)
8. Zhang, Xu Dong: 4 articles (08/2013 - 05/2003)
9. Grant, Steven: 4 articles (11/2009 - 11/2002)
10. Dent, Paul: 4 articles (11/2009 - 11/2002)

Related Diseases

1. Neoplasms (Cancer)
2. Brain Ischemia (Cerebral Ischemia)
3. Anoxia (Hypoxia)
4. Hyperalgesia
5. Pancreatic Neoplasms (Pancreatic Cancer)

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. Estrogens (Estrogen)
3. Protein Kinases (Protein Kinase)
4. 2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
5. Mitogen-Activated Protein Kinase 3
6. PD 98059
7. Proteins (Proteins, Gene)
8. Butadienes
9. Caspase 3 (Caspase-3)
10. MAP Kinase Kinase 1

Related Therapies and Procedures

1. Spinal Injections
2. Heterologous Transplantation (Xenotransplantation)
3. Acupuncture Points (Acupuncture Point)
4. Ligation
5. Drug Therapy (Chemotherapy)